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Abstract
Background: Post-translational modifications are viewed as an important mechanism for controlling protein
function and are believed to be involved in multiple important diseases. However, their profiling using laboratory-
based techniques remain challenging. Therefore, making the development of accurate computational methods to
predict post-translational modifications is particularly important for making progress in this area of research.
Results: This work explores the use of four half-sphere exposure-based features for computational prediction of
sumoylation sites. Unlike most of the previously proposed approaches, which focused on patterns of amino acid
co-occurrence, we were able to demonstrate that protein structural based features could be sufficiently informative
to achieve good predictive performance. The evaluation of our method has demonstrated high sensitivity (0.9),
accuracy (0.89) and Matthew’s correlation coefficient (0.78–0.79). We have compared these results to the recently
released pSumo-CD method and were able to demonstrate better performance of our method on the same
evaluation dataset.
Conclusions: The proposed predictor HseSUMO uses half-sphere exposures of amino acids to predict sumoylation
sites. It has shown promising results on a benchmark dataset when compared with the state-of-the-art method.
The extracted data of this study can be accessed at https://github.com/YosvanyLopez/HseSUMO.
Background
Post-translational modifications (PTMs) of proteins are
enzyme-medicated covalent alterations of protein sequence
during which a chemical group can be added to a particu-
lar residue or sequence is cleaved at a specific location [1].
These modifications greatly expand the range of possible
final forms of proteins that can be generated from the
same genomic sequence [2]. PTMs also play an important
role in modulation of all aspects of protein function, in
particular, they can determine protein localization within
the cell [3], mediate signal transduction [4, 5], activate or
deactivate enzymes and transporters [6, 7] and underlie
protein degradation and recycling [8]. Despite this critical
role PTMs play in all living systems, accurate identification
of all types of these modifications using laboratory methods
remains challenging. Some pertinent problems include [9]:
(1) isolation of specific proteins with modification (s) of
interest from the highly diverse and biochemically hetero-
geneous proteome (2) masking effects of the highly abun-
dant proteins in the sample, which can make isolation
using standard immunoprecipitation and chromatographic
methods difficult and (3) the diversity and molecular
complexity of possible PTMs themselves.
Positions at which PTMs are possible are usually highly
specific to particular protein residues and are governed by
the amino acid motifs at the site and three-dimensional
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conformation of the protein [1]. Therefore, a priori identi-
fication of the sites and proteins where particular PTMs
can occur can be an important way to narrow down the
possibilities and facilitate their experimental verification.
This sequence-based specificity allows for the possibility
of identification of these sites using computational pre-
dictive approaches and development of such methods is
an area of active research [10].
One of the important types of PTMs, called sumoyla-
tion, involves reversible covalent bonding of small
ubiquitin-like modifier proteins SUMO1, SUMO2 and
SUMO3 [11]. This modification is of particular interest
due to its involvement in neurodegenerative [12–14] and
immune-related diseases [15–17], as well as cancer [18,
19]. Sumoylation involves several enzymatic steps and was
previously reported to be commonly found at ψK.E/D (or
inverse E/D.Kψ) motif, where ψ can any of the hydropho-
bic amino acids [20]. However most recent results indicate
that as many as half of all sumoylation sites do not actu-
ally follow this pattern [4], therefore simple motif-based
strategies are likely to be insufficient for good predictive
performance on these more recent data.
To date, multiple sequence-based approaches to predic-
tion of sumoylation sites have been proposed. Some earlier
approaches are SUMOsp [21], which employs a group-
based prediction system (GPS) similarity clustering and
SUMOpre [22], which works by fitting a multiple linear re-
gression model to a 7-residue sequence window. In 2009,
an updated version of the SUMOsp algorithm was released
that achieved higher specificity and accuracy than any other
tools available at the time and proved the utility of their
original GPS-based approach. Next, SUMOhydro [23] was
proposed that introduced an improved dataset of
experimentally-determined sumoylation sites and explored
an original type of predictive feature (binary-encoded
hydrophobicity pattern) in combination with a support vec-
tor machine classifier. GPS-SUMO [24] further refined a
GPS-based approach proposed in SUMOsp 1.0 and 2.0,
and combined it with particle swarm optimization algo-
rithm. Then, an important shift in direction was proposed
by [25], who were the first to use protein structural features
for prediction of sumoylation sites, in particular, predicted
disorder and confirmation flexibility. And, finally, the most
recent methods are pSumo-CD [26] and SUMO_LDA [27].
The former applied a covariance discriminant algorithm in
combination with pseudo amino acid composition model.
The latter works by computing a position-specific amino
acid propensity matrix at locations of interest, which was
then used in combination with linear discriminant analysis.
Although good performance results have been consist-
ently reported even in the very early studies, it appears
likely that these efforts have been severely limited by the
amount of experimental data that was available at the
time. Most importantly, it appears that the proportion of
the sumoylation sites that do not follow the consensus
motif was previously greatly underestimated (e.g. it was
assumed to be only about 23% in [21]) until sufficient
data were collected in more recent studies [4]. This indi-
cates that the problem is both more complex than was
previously thought and that structural patterns of the
protein fold likely play an important role in determining
suitable sumoylation sites. However, a vast majority of
previously proposed methods have focused on features
chiefly based on amino acid occurrence patterns at the
sites of interest. To explore the usefulness of structural
features [28–33], we propose a novel method, Hse-
SUMO that uses a combination of four different
half-sphere exposure (HSE) measures, originally devel-
oped to characterize solvent exposure at particular
amino acid residues [34]. We demonstrate that a com-
bination of these features is highly promising for predic-
tion of sumoylation sites and we were able to achieve
very good levels of performance even using a relatively
simple decision tree classifier (0.89 area under ROC
curve for 6, 8 and 10-fold cross-validation schemes).
HSE measure is used for feature computation. It is an
alternative measure of the solvent exposure of the amino
acids and its use for sumoylation site prediction has
shown promising results when compared with the existing
state-of-the-art sumoylation site predictor. This indicates
that HSE contains the complementary information of the
amino acids to identity the sumoylation sites. In the litera-
ture, the HSE measure has been shown to contain import-
ant information in the related field of research [35, 36].
In addition, the imbalance of data deteriorates the per-
formance. To tackle this, we have used the under-sampling
technique to obtain the balanced sampling. Furthermore,
to report the statistical significance of the HseSUMO, we
performed k-fold cross-validation and reported perform-
ance measures such as sensitivity, specificity, accuracy and
MCC. For sumoylation site prediction, it is very crucial to
have high sensitivity as detecting affected lysine sites are of
prime importance. Thus, HseSUMO achieved performance
improvement of 36.5% in terms of sensitivity and 16.7% in
terms of accuracy.
Methods
Dataset description
All data used in this analysis is from the Compendium
of Protein Lysine Modifications (CPLM) database [37], a
resource which manually curates information about 12
different types of lysine PTMs from literature. From
these data we have identified a subset of all proteins
which were profiled for sumoylation, giving 448 proteins
in total that had 780 positive examples of sumoylated
sites and 21,353 confirmed non-sumoylated sites. We fil-
tered out sequences over 40% sequential similarity using
CD-HIT [38]. Therefore, our benchmark dataset has less
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than 40% sequential similarity. The difference between
positive and negative samples creates class imbalance
problem. The two commonly used strategies to overcome
this problem are over-sampling and under-sampling. The
over-sampling procedure could increase the probability of
over-fitting the model, and under-sampling often provides
a modest solution for a given model. Therefore, we
selected under-sampling procedure like NearMiss method
[39] by employing the imbalanced-learn package of py-
thon. After applying NearMiss method we ended up with
780 negative and 780 positive samples.
Half-sphere exposure feature computation
Half-sphere exposure (HSE) is a solvent exposure measure-
ment similar to Contact Number (CN) [40], and Accessible
Surface Area (ASA) [41]. In contrast to ASA and CN that
do not provide explicit information regarding the orienta-
tion of side chains which is important on the conformation
of the 3D structure of the proteins and its interaction with
other macro-molecules HSE is designed to attain such
information [42]. HSE is introduced in [42] and can be
calculated in two ways by splitting the sphere around the
Cα atom (with radius R typically equal to 12 Å) into two
half-spheres either along the vector of Cα-Cβ atoms or a
pseudovector of Cα-Cβ generated from the sum of vectors
Cαi − 1 −Cαi and Cαi+ 1 −Cαi. The first one is referred to as
HSEβ and the second one as HSEα.
For HSEβ, the half-sphere containing the Cβ atom is
then defined as upper and the other as down
half-spheres and the numbers of Cα atoms enclosed in
these two half-spheres were named as HSEβ-up and
HSEβ-down, respectively. An illustration for HSE is
given in Fig. 1. For HSEα, the half-sphere perpendicular
to the sum of Cαi − 1 − Cαi and Cαi + 1 −Cαi vectors is
HSEα-up and another one is HSEα-down. The main
difference between HSEβ and HSEα is that calculating
the second does not require the position of Cβ which is
hard to determine for some cases. It was shown in [42]
that HSEα is a better measurement for solvent exposure
than CN, ASA and even HSEβ. However, the use of
HSEα and HSEβ simultaneously has shown to be
complementary [43, 44].
Lysine residue description
Lysine residue (sumoylated or non-sumoylated) is
described by a segment of 31 amino acids (15 upstream
and 15 downstream) as done by previous studies [45–51].
If a lysine residue is present in any terminus of a protein
sequence and if the segment of 31 residues is not possible
then we adjusted the segment by employing mirror of
amino acids [45]. Suppose lysine residue site is denoted by
K then a segment of 31 amino acids will be given as S = {A
−15, A−14,…, A−1, L, A1,…, A14, A15}. Therefore, a lysine K
consists of 31 HSE features and it is characterized by the
124-dimensional feature vector. The high dimensionality
can be further reduced by feature selection techniques
[52–54].
Model training
The model was trained using a decision tree-based classi-
fier. Despite its simplicity, the decision tree classifier has
the advantage of allowing easy interpretation of the under-
lying model, which can facilitate discovery of biologically
meaningful patterns captured by the model. To get an ac-
curate measure of performance we have used a repeated
cross-validation approach. There are three cross-validation
methods, i.e., independent dataset test, sub-sampling (or
K-fold cross-validation) test, and jackknife test, often used
to evaluate the anticipated success rate of a predictor.
Among the three methods, however, the jackknife test is
deemed the least arbitrary and most objective one and
hence has been widely recognized and increasingly adopted
Fig. 1 An illustration of half-sphere exposure of amino acid
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by investigators to examine the quality of various predic-
tors [55–59]. In the jackknife test, each sequence in the
training dataset is in turn singled out as an independent
test sample and all the rule-parameters are calculated with-
out including the one being identified. Though Jackknife
test is the most effective, due to its computational expense
we have adopted the K-fold test which is an alternative
evaluation method and has been widely used in many
protein-related problems [33, 60–62]. Briefly, in K-fold the
dataset was partitioned into k approximately equally-sized
folds (in this case either 6, 8 or 10) [63]. In turn, each of
the subsets was set aside and used for validation of the
model trained on the remaining k-1 folds. To train the pre-
dictor, we used the Python implementation of decision
trees. The quality of a split was measured with Gini impur-
ity and “best” was selected as the strategy for choosing the
split at each node. Moreover, only two samples were re-
quired for splitting an internal node.
Evaluation of model performance
According to established evaluation framework, we de-
fine the number of instances where sumoylated sites
were predicted, either correctly or incorrectly as true
positives (TP) or false positives (FP) respectively. Simi-
larly, for non-sumoylated sites, counts of correct or in-
correct predictions are defined as false negatives (FN) or
true negatives (TN). Then sensitivity (also known as true
positive rate) is a proportion of correctly predicted
sumoylated sites among all real sites:
Sens ¼ TP
FN þ TP ð1Þ
and specificity is a proportion of all correctly predicted
non-sumoylated sites among all negative predictions:
Spec ¼ TN
FP þ TN ð2Þ
The other two performance metrics are accuracy and
Matthew’s correlation coefficient which are defined
according to the following formulae:
Accuracy ¼ TN þ TP
TN þ FN þ TP þ FP ð3Þ
MCC ¼ TP  TNð Þ− FP  FNð Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TN þ FPð Þ  TP þ FNð Þ  TP þ FPð Þ  TN þ FNð Þp
ð4Þ
The last evaluation metric used was the area under
receiver-operator characteristic (ROC) curve. The curve
is computed by considering how the trade-off between
sensitivity and false positive rate changes at a range of
different cut-offs of class prediction probability (M)
returned by a given classifier. Here, the false positive rate
is defined as follows:
FPR ¼ FP
TN þ FP ð5Þ
And, finally, given these definitions the area under
(AUC) the ROC curve is described as follows:
AUC Mð Þ ¼
Z −∞
∞
Sens Mð Þ  −FPR0 Mð Þð Þ dM ð6Þ
To verify that the performance of the classifier is robust,
ROC-AUC measures were averaged across all cross-valid-
ation folds with the same fold number, and the resulting
average curves, AUC values and their standard deviations
are shown in Fig. 2. We also report the performance of the
most recently released alternative method called
pSumo-CD. The comparison was done by annotating all
proteins in our dataset using the pSumo-CD web server.
The resulting annotations were processed in an identical
way to those of our method and the same set of four
performance metrics were computed.
Results and discussion
The results of our evaluation are shown in Table 1, which
showed that our method was able to outperform
pSumo-CD on according to all metrics with exception of
specificity. However, we note that there is a trade-off
between the sensitivity and specificity measures, which can
be realized by altering a threshold of the classifier at which
a particular prediction is made. Notably, the sensitivity of
pSUMO-CD is considerably lower, and more robust mea-
sures like accuracy (16.7% higher) and Matthew’s correl-
ation coefficient (0.296 higher) are considerably better for
our method. The difference between performances
achieved for different k-folds validation schemes was also
relatively small, indicating that over-fitting is likely to be
relatively low. We also would like to point out that as
pSumo-CD is, in essence, a machine learning method it will
inherently have better performance on the samples from
the original dataset used to train its model. Although from
the description of the method we were able to deduce that
there might be an overlap between our evaluation dataset
and training dataset of pSumo-CD, not enough information
was provided to allow us to identify and exclude these
samples. Therefore, for this reason, the evaluation is likely
to be biased in favor of pSumo-CD.
To compare the HseSUMO with pSumo-CD predictors,
we have analyzed the sumoylation sites predicted by Hse-
SUMO and pSumo-CD. (Additional file 1: Supplementary
Table S1) shows the total number of sites predicted for 448
proteins analyzed in this paper. It is observed that out of
780 positives sites, HseSUMO correctly predicted 698 sites
compared to 418 sites predicted by pSumo-CD. Thus, 35%
increase in the prediction ratio is noted for HseSUMO.
Moreover, evaluating the performance of HseSUMO for
different folds resulted with higher value of sensitivity for
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10-fold cross-validation, while for 6-fold cross-validation a
better performance was observed in terms of specificity,
accuracy and MCC measures. Overall, there is a very little
change in the performance measures for different folds
when comparing HseSUMO and pSumo-CD.
In detail, the highest sensitivity by HseSUMO was noted
as 0.904. The specificity was in the range of 0.872 and
0.895. The specificity of pSumo-CD was the highest achiev-
ing at 0.921, however, it provided sensitivity of 0.536 only.
Thus, most of the sumoylation sites were not detected. The
accuracy for HseSUMO was in the range of 0.888 and
0.895, however, for pSUMO-CD we achieved 0.728. The
MCC measure was in the range 0.776 and 0.790 for Hse-
SUMO, while pSUMO-CD was able to achieve 0.494 MCC
score. In summary, we were able to achieve performance
improvement of 36.5, 16.7, and 29.6% in terms of sensitiv-
ity, accuracy and MCC, respectively. However, pSumo-CD
only showed high performance on specificity measure.
Although the metrics reported above are commonly used
to evaluate the performance of particular machine learning
classifiers, they are all subject to a limitation of only being
applicable after a class prediction has been made. However,
most classifiers can return a score rather than hard
prediction and the final prediction is generated by applying
a particular cut-off to that score. Depending on the cost
attached to making an error of particular type different
threshold can be chosen. Therefore, an analysis of the area
under the ROC curve, which summarizes performance at
all possible threshold can potentially be more useful. The
results of the ROC-AUC analysis of our method are shown
in Fig. 2; average AUC value for all fold numbers was
recorded at 0.89, indicating stable performance. In all cases,
the higher standard deviation was associated with lower
score cut-offs.
Our method was able to achieve highly competitive
results despite forgoing pattern-based features that were
key for many previous approaches, and, importantly, also
performed well on an updated dataset that incorporated
greater proportion of sites. These results indicate that
structural features, e.g. HSE features are likely important
for underlying biology of sumoylation mechanism and
could be highly promising features for improvements in
computational prediction of both sumoylation sites as
well as other types of PTMs.
Conclusions
Despite recent progress in the development of better
laboratory-based PTM detection methods, their experi-
mental identification remains challenging. In this study,
Fig. 2 Receiver operating characteristic curves of HseSUMO
performance. Three panels show results for 6-fold (a), 8-fold (b),
and 10-fold (c) evaluation schemes
Table 1 Performance evaluation of HseSUMO. CV refers to the
cross-validation scheme for 6-fold, 8-fold and 10-fold
Methods Sensitivity Specificity Accuracy MCC
pSumo-CD 0.536 0.921 0.728 0.494
HseSUMO (CV- 6 0.895 0.895 0.895 0.790
HseSUMO (CV- 8) 0.897 0.879 0.888 0.777
HseSUMO (CV- 10) 0.904 0.872 0.888 0.776
The highest values are depicted as bold faces
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we propose a new, accurate method for prediction of
sumoylation sites, an important type of PTM underlying
multiple human diseases. Our method demonstrates the
predictive power of features based on protein structure
in case of sumoylation. This finding is of great interest,
as all of the currently available methods in this area are
based on features derived from some form of amino acid
co-occurrence patterns, but recent experimental results
indicate that over half of all known sumoylation sites are
not associated with a clear amino acid motif [4]. Further-
more, to make current predictors more practical to the
scientific community, a user friendly web-server is often
developed [36, 64–66]. Therefore, we will make an effort
to provide a flexible web-server for the method in the near
future, which will undoubtedly contribute to enhance the
ongoing work of experiment scientists and medical
researchers alike. Meanwhile, interested researchers can
access to the scripts and training matrices available at
https://github.com/YosvanyLopez/HseSUMO.
Additional file
Additional file 1: Supplementary Table S1. Prediction of protein
sequences by predictors (XLS 58 kb)
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